Elevance Health (ELV) reported Q1 adjusted earnings Tuesday of $11.97 per diluted share, up from $10.83 a year earlier.
A single analyst polled by FactSet expected operating EPS of $10.95.
Operating revenue for the quarter ended March 31 was $48.77 billion compared with $42.27 billion a year earlier.
Analysts surveyed by FactSet expected $46.30 billion.
The company reaffirmed its 2025 adjusted diluted EPS guidance range of $34.15 to $34.85.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.